Hospitalizations
Also known as: Hospitalisation / Hospitalization / Hospitalisations / Hospitalized / Hospitalization NOS / Inpatient care (regime/therapy)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00026 | Anakinra | A recombinant form of human interleukin-1 receptor antagonist used in the treatment of rheumatoid arthritis, neonatal-onset multisystem inflammatory disease and deficiency of interleukin-1 receptor antagonist (DIRA). |
| DB01076 | Atorvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
| DB11817 | Baricitinib | A Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis that has responded poorly to at least one TNF antagonist. |
| DB12364 | Betrixaban | A Factor Xa inhibitor used for prophylaxis of venous thromboembolism in hospitalized patients. |
| DB08907 | Canagliflozin | A sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage hyperglycemia in type 2 diabetes mellitus (DM). Also used to reduce the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 DM. |
| DB06292 | Dapagliflozin | A sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus. |
| DB09038 | Empagliflozin | An SGLT2 inhibitor used to manage type 2 diabetes mellitus. |
| DB16165 | Finerenone | A nonsteroidal mineralocorticoid receptor antagonist indicated to lower the risk of eGFR decline, end stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure in chronic kidney disease associated with type 2 diabetes. |
| DB08887 | Icosapent ethyl | An ethyl ester of eicosapentaenoic acid (EPA) that reduces synthesis and enhances clearance of triglycerides that is used to treat patients with severe hypertriglyceridemia. |
| DB00331 | Metformin | A biguanide antihyperglycemic used in conjunction with diet and exercise for glycemic control in type 2 diabetes mellitus. It is also used off-label for insulin resistance in polycystic ovary syndrome (PCOS). |
| DB15661 | Molnupiravir | An orally bioavailable isopropylester cytidine analog used to treat COVID-19. |
| DB14500 | Potassium | A medication used to treat hypokalemic conditions and to clear the colon prior to colonoscopy. |
| DB14761 | Remdesivir | A nucleoside analog used to treat RNA virus infections including COVID-19. |
| DB16416 | Vilobelimab | An antibody directed against anti-human complement factor 5a is used to treat COVID-19 in adults for emergency use. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01593 | Zinc | 1 | Completed | 1 |
| DB16691 | Nirmatrelvir | 2 | Withdrawn | 1 |
| DB00503 | Ritonavir | 2 | Withdrawn | 1 |
| DB00878 | Chlorhexidine | 4 | Completed | 1 |
| DB00828 | Fosfomycin | 4 | Completed | 1 |
| DB00047 | Insulin glargine | 4 | Completed | 1 |
| DB00046 | Insulin lispro | 4 | Completed | 1 |
| DB06812 | Povidone-iodine | 4 | Completed | 1 |
| DB01261 | Sitagliptin | 4 | Completed | 1 |
| DB01015 | Sulfamethoxazole | 4 | Completed | 1 |
| DB00440 | Trimethoprim | 4 | Completed | 1 |
| DB00898 | Ethanol | Not Available | Not Yet Recruiting | 1 |
| DB06822 | Tinzaparin | Not Available | Recruiting | 1 |
| DB01593 | Zinc | Not Available | Completed | 1 |